Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medicalgorithmics S.A. Capital/Financing Update 2026

Jun 10, 2026

5705_rns_2026-06-10_ce03a73d-ada2-4cbd-999b-740f2d076e01.html

Capital/Financing Update

Open in viewer

Opens in your device viewer

Report Content Execution of an agreement to an annex to the loan agreement with BioFund

Current report no.: 25/2026

Date: 10.06.2026

Legal basis: Article 17(1) of MAR - inside information.

The Management Board of Medicalgorithmics S.A. with its registeredoffice in Warsaw (the "Issuer" or the "Company") announces that on June10 2026, it entered into an agreement (the "Agreement") to Annex No. 2dated 27 April 2026 (the "Annex") to the loan agreement concludedbetween the Company and the Company's shareholder - BioFund CapitalManagement LLC (USA) on 29 November 2024, as amended by an annex dated15 April 2025.

Pursuant to the Agreement, the parties resolved to amend the date of thecondition subsequent set forth in the Annex, as disclosed by the Companyin current report No. 13/2026 dated 27 April 2026, by extending thedeadline specified in the Annex to 31 July 2026.

In all other respects, the provisions of the Annex remain unchanged andin full force and effect.